DNJHEHMFFZQPJC-GCJKJVERSA-N
C31H36ClF3N8O6 — CID 155614931
Data last refreshed: (MolForge compound catalog, from PubChem)
About DNJHEHMFFZQPJC-GCJKJVERSA-N
DNJHEHMFFZQPJC-GCJKJVERSA-N (PubChem CID 155614931) has the molecular formula C31H36ClF3N8O6 and a molecular weight of 709.13 g/mol. Its IUPAC name is tert-butyl (2S,4R)-2-[4-[2-chloro-4-[[1-methyl-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]imidazole-2-carbonyl]amino]benzoyl]piperazine-1-carbonyl]-4-hydroxypyrrolidine-1-carboxylate.
Molecular Properties
| Compound Name | DNJHEHMFFZQPJC-GCJKJVERSA-N |
|---|---|
| PubChem CID | 155614931 |
| Molecular Formula | C31H36ClF3N8O6 |
| Molecular Weight | 709.13 g/mol |
| Exact Mass | 708.24 |
| IUPAC Name | tert-butyl (2S,4R)-2-[4-[2-chloro-4-[[1-methyl-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]imidazole-2-carbonyl]amino]benzoyl]piperazine-1-carbonyl]-4-hydroxypyrrolidine-1-carboxylate |
| SMILES | Cn1cc(-c2cnc(C(=O)Nc3ccc(C(=O)N4CCN(C(=O)[C@@H]5C[C@@H](O)CN5C(=O)OC(C)(C)C)CC4)c(Cl)c3)n2C)c(C(F)(F)F)n1 |
| InChI | InChI=1S/C31H36ClF3N8O6/c1-30(2,3)49-29(48)43-15-18(44)13-22(43)28(47)42-10-8-41(9-11-42)27(46)19-7-6-17(12-21(19)32)37-26(45)25-36-14-23(40(25)5)20-16-39(4)38-24(20)31(33,34)35/h6-7,12,14,16,18,22,44H,8-11,13,15H2,1-5H3,(H,37,45)/t18-,22+/m1/s1 |
| InChIKey | DNJHEHMFFZQPJC-GCJKJVERSA-N |
| XLogP | 3.40 |
| TPSA | 155.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 709.13 |
| LogP ≤ 5 | 3.40 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155614931 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.